Prognostic value of post-transplantation measurable residual disease in patients with myelodysplastic syndrome: A prospective cohort study [0.03%]
异基因造血干细胞移植后检测残留病在骨髓衰竭性疾病中的预后价值：前瞻性队列研究
Yuewen Wang,Lanping Xu,Yu Wang et al.
Yuewen Wang et al.
Objective: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only potentially curative method for treating myelodysplastic syndrome (MDS). Post-HSCT measurable residual disease (post-HSCT MRD) is assoc...
Preface to Special Issue: Advances in hematopoietic stem cell transplantation for high-risk hematologic malignancies [0.03%]
高危血液系统恶性肿瘤的造血干细胞移植进展专辑前言
Xiaojun Huang
Xiaojun Huang
Homoharringtonine combined with venetoclax and azacitidine: An effective and safe regimen for patients with refractory/relapsed acute myeloid leukemia [0.03%]
海乐亭联合维奈克拉和地西他滨治疗难治复发急性髓系白血病有效且安全
Yiling Ye,Qifa Liu,Hua Jin
Yiling Ye
Machine learning-based prediction model for postoperative complications in gastric and colorectal cancer: A prospective nationwide multi-center study [0.03%]
基于机器学习的胃癌和结直肠癌术后并发症预测模型的前瞻性多中心研究
Jun Lu,Zhouqiao Wu,Jie Chen et al.
Jun Lu et al.
Objective: This study aimed to develop and validate a predictive model for postoperative complications in gastrointestinal cancer patients using a large multicenter database, based on machine learning algorithms. ...
Association of lifestyle factors with breast cancer incidence: An overview of systematic reviews [0.03%]
生活方式因素与乳腺癌发病率关系的系统评价概述
Md Sohel Rana,Md Mijanur Rahman,Jannah Baker et al.
Md Sohel Rana et al.
Objective: Heterogeneity in the evidence of association between lifestyle factors and breast cancer (BC) incidence hampers initiatives to modify BC risk. This overview aims to synthesise evidence from systematic reviews (...
Outcomes of adult patients with B-cell acute lymphoblastic leukemia with or without blinatumomab as bridging therapy prior to allogeneic hematopoietic stem cell transplantation [0.03%]
allo-HSCT前使用或未使用Blinittumomab作为衔接治疗对成人B淋巴母细胞白血病/淋巴瘤患者预后的临床研究
Jiayu Huang,Yi Xia,Yuhang Cheng et al.
Jiayu Huang et al.
Strategic innovations: Tackling challenges of immunotherapy in acute myeloid leukemia [0.03%]
战略创新：克服急性髓系白血病免疫治疗的挑战
Haolong Lin,Tao Wang,Jia Wei
Haolong Lin
The clinical efficacy of immunotherapy in acute myeloid leukemia (AML) remains significantly limited by early relapse and treatment-associated toxicities. This review examines recent advances in antibody- and cell-based immunotherapies for ...
Burden of pancreatic cancer among the Western Pacific Region and association with human resources for health from 1990 to 2021: Results from the Global Burden of Disease Study 2021 [0.03%]
1990至2021年西方太平洋地区胰腺癌负担及卫生人力关联：来自全球疾病负担研究（GBD 2021）的证据
Feilong Ning,Liwei Ren,Shuo Liu et al.
Feilong Ning et al.
Objective: Pancreatic cancer is a global health challenge, yet the Western Pacific Region (WPR) lacks comprehensive analysis of its burden and human resources for health (HRH) distribution. This study aims to assess trend...
Molecular insights into immune evasion and therapeutic paradigms in pancreatic cancer [0.03%]
胰腺癌免疫逃逸的分子机制及治疗策略研究进展
Ming Li,Renyu Zhou,Yu Qiu et al.
Ming Li et al.
Pancreatic cancer, particularly pancreatic ductal adenocarcinoma (PDAC), is one of the most lethal malignancies, which is characterized by a complex tumor microenvironment (TME) that fosters immune evasion and treatment resistance. Recent g...